Arkolith/Insider Trading/EYPT/Form 4

Lurker Nancy

DirectorEyePoint Pharmaceuticals, Inc. (EYPT) · full profile →Form 4 · filed Dec 1, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$10K
Net Open-Market Flow
-$10K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 28, 2025Sell(S)500$14.95$7K216K
Nov 26, 2025Sell(S)200$14.95$3K216K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001450485-25-000007) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML